Skip to main content
ITGR
NYSE Life Sciences

Integer Holdings Initiates Strategic Review, Weighs Sale or Merger

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
9
Price
$83.67
Mkt Cap
$2.851B
52W Low
$62
52W High
$127.56
Market data snapshot near publication time

summarizeSummary

Integer Holdings Corp's Board of Directors has initiated a strategic review to maximize stockholder value, explicitly considering a full range of potential opportunities including a sale, merger, or strategic business combination. This significant corporate action, advised by Goldman Sachs, comes as the company notes strong interest from external parties. While no deadline or definitive timeline is set, this development could lead to a substantial premium for shareholders, fundamentally altering the investment thesis. Traders will closely monitor any updates regarding potential bidders or the outcome of the review process.

At the time of this announcement, ITGR was trading at $83.67 on NYSE in the Life Sciences sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $62.00 to $127.56. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


show_chartPrice Chart

Share this article

Copied!

feed ITGR - Latest Insights

ITGR
Apr 30, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
9
ITGR
Apr 30, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
ITGR
Apr 30, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
ITGR
Apr 06, 2026, 4:56 PM EDT
Filing Type: DEF 14A
Importance Score:
7
ITGR
Mar 12, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
8
ITGR
Feb 23, 2026, 8:03 AM EST
Filing Type: 10-K
Importance Score:
8
ITGR
Feb 19, 2026, 8:14 AM EST
Filing Type: 8-K
Importance Score:
8